Published in Cell Transplant on April 04, 2014
The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases. J Cell Mol Med (2014) 0.89
De Novo Donor-Specific HLA Antibody Formation in Two Patients With Crigler-Najjar Syndrome Type I Following Human Hepatocyte Transplantation With Partial Hepatectomy Preconditioning. Am J Transplant (2015) 0.79
Role of Chromatin Structural Changes in Regulating Human CYP3A Ontogeny. Drug Metab Dispos (2016) 0.75
Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol (2016) 0.75
Mapping the genetic architecture of gene expression in human liver. PLoS Biol (2008) 19.44
An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med (2006) 5.02
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells (2007) 3.39
Human hepatocyte transplantation: worldwide results. Transplantation (2006) 3.02
Stem cell characteristics of amniotic epithelial cells. Stem Cells (2005) 2.66
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. Am J Obstet Gynecol (2005) 2.51
Qualitative and quantitative measures of various compounded formulations of 17-alpha hydroxyprogesterone caproate. Am J Obstet Gynecol (2013) 2.36
Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol (2006) 2.21
Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res (2010) 2.06
Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology (2006) 2.04
Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in mice. J Hepatol (2009) 1.64
A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods (2011) 1.60
EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION. Surg Forum (1986) 1.59
Resetting the transcription factor network reverses terminal chronic hepatic failure. J Clin Invest (2015) 1.58
Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels. Tissue Eng Part A (2010) 1.50
Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics (2003) 1.49
Sertraline hepatotoxicity: report of a case and review of the literature. Dig Dis Sci (2008) 1.49
Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev (2006) 1.48
Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology (2003) 1.48
Hepatic repopulation with stably transduced conditionally immortalized hepatocytes in the Gunn rat. J Hepatol (2008) 1.47
Parent perspectives on decisions to participate in a phase I hepatocyte transplant trial. Pediatr Transplant (2013) 1.46
Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3). Mol Pharmacol (2007) 1.46
Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol (2010) 1.41
Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression. Drug Metab Dispos (2007) 1.40
Pharmacokinetics of oseltamivir among pregnant and nonpregnant women. Am J Obstet Gynecol (2011) 1.36
The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry (2010) 1.32
Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell (2010) 1.32
Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant (2003) 1.31
Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant (2012) 1.31
Frequent aneuploidy among normal human hepatocytes. Gastroenterology (2011) 1.30
Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol Appl Pharmacol (2007) 1.29
Identification of enzymes involved in the metabolism of 17alpha-hydroxyprogesterone caproate: an effective agent for prevention of preterm birth. Drug Metab Dispos (2008) 1.25
Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation. Am J Obstet Gynecol (2011) 1.24
Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation. Hepatology (2009) 1.23
Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation. Am J Obstet Gynecol (2012) 1.22
Differentiation of mouse embryonic stem cells to hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines. Nat Protoc (2007) 1.22
Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metab Dispos (2004) 1.19
Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J Pharmacol Exp Ther (2005) 1.19
Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes. Hepatology (2002) 1.18
Simultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS). J Pharm Biomed Anal (2008) 1.18
Human hepatocyte transplantation. Methods Mol Biol (2010) 1.17
Functional evolution of the vitamin D and pregnane X receptors. BMC Evol Biol (2007) 1.17
Development and application of purified tissue dissociation enzyme mixtures for human hepatocyte isolation. Cell Transplant (2011) 1.16
Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor. Mol Pharmacol (2005) 1.14
A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine. Drug Metab Dispos (2008) 1.14
Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant (2005) 1.12
The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl (2002) 1.11
The prevalence of hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol (2004) 1.09
Hepatocyte transplantation. Transplantation (2004) 1.09
Acute pancreatitis associated with the use of peginterferon. Pancreas (2007) 1.09
ChREBP mediates glucose-stimulated pancreatic β-cell proliferation. Diabetes (2012) 1.08
Tacrolimus dosage requirements after initiation of azole antifungal therapy in pediatric thoracic organ transplantation. Pediatr Transplant (2003) 1.08
Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats. Toxicol Sci (2003) 1.08
Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4alpha and pregnane X receptor. J Pharmacol Exp Ther (2007) 1.07
The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis. Hepatology (2012) 1.07
MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype. Clin Pharmacol Ther (2006) 1.06
Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen. Antimicrob Agents Chemother (2006) 1.06
Identification of stem cell marker-positive cells by immunofluorescence in term human amnion. J Reprod Immunol (2007) 1.06
MicroRNA hsa-miR-613 targets the human LXRα gene and mediates a feedback loop of LXRα autoregulation. Mol Endocrinol (2011) 1.05
Effects of bergamottin on human and monkey drug-metabolizing enzymes in primary cultured hepatocytes. Drug Metab Dispos (2002) 1.04
PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel. Bioconjug Chem (2012) 1.04
mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesis. Cancer Res (2013) 1.04
Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. Toxicol Sci (2010) 1.03
Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol (2010) 1.03
PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. Biomaterials (2012) 1.03
Side population cells derived from adult human liver generate hepatocyte-like cells in vitro. Dig Dis Sci (2005) 1.02
Acute pancreatitis attributed to the use of pegylated interferon in a patient with chronic hepatitis C. J Gastrointestin Liver Dis (2007) 1.02
Review of hepatocyte transplantation. J Hepatobiliary Pancreat Surg (2008) 1.01
Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity. Dig Dis Sci (2007) 1.00
Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel. Mol Pharm (2013) 1.00
Hepatic differentiation of amniotic epithelial cells. Hepatology (2011) 0.99
Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone. Toxicol Sci (2006) 0.99
Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors. Am J Pathol (2005) 0.97
PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel. Bioconjug Chem (2013) 0.96
Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease. Mol Ther (2009) 0.96
A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. Eur J Biochem (2003) 0.96
Spontaneous hepatic repopulation in transgenic mice expressing mutant human α1-antitrypsin by wild-type donor hepatocytes. J Clin Invest (2011) 0.96
Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures. Toxicol Appl Pharmacol (2008) 0.96
Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death. J Hepatol (2007) 0.96